Formycon and Zydus sign exclusive agreement for FYB206 supply
On market launch of the product, Formycon will receive a mid–double-digit-share of gross profits in the region.
Drug Manufacturers
Denali makes $275m funding agreement with Royalty Pharma
Takeda and Innovent fulfil close conditions for ADC and IO therapies
Made Scientific and Cellergy partner to advance CLG-001
Moderna to onshore drug product manufacturing to Massachusetts
CPHI 2025: ‘handprint’ metric bridges pharma sustainability and economic value
Chiesi and Aliada sign licence deal for enzyme replacement therapies
Novartis opens California site for RLT manufacturing
